EP3172232
Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.7.2015EP published:
27.12.2023EP application number:
15738925.5
EP translation filed:
5.2.2024Grant published:
15.3.2024EPO information:
European Patent Register
Max expiry date:
16.7.2035Expiry date:
16.7.2026Next due date:
31.7.2026
Title in English:
SITE DIRECTED MUTAGENESIS OF TREM-1 ANTIBODIES FOR DECREASING VISCOSITY.Language of the patent:
English
Timeline
Today
17.7.2015EP application
27.12.2023EP Publication
5.2.2024Translation submitted
15.3.2024Registration published
16.7.2026Expires
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880 Bagsværd, DK
Inventor
Name:
HENRIKSEN, AnetteAddress:
2880 Bagsvaerd, DK
Name:
KJAERGAARD, KristianAddress:
2750 Ballerup, DK
Name:
WESTPHAL STENNICKE, VibekeAddress:
2980 Kokkedal, DK
Name:
WIBERG, CharlotteAddress:
2880 Bagsvaerd, DK
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
14177547Date:
17.7.2014Country:
EP
Number:
14194893Date:
26.11.2014Country:
EP
Classification
Categories:
C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 7.6.2024
Expires: 16.7.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 8.7.2025
Expires: 16.7.2026
Payer: Árnason Faktor ehf.